Systemic-onset Juvenile Idiopathic Arthritis
📧 Sign up to get email alerts when something new happens for Systemic-onset Juvenile Idiopathic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS [Phase 2, Phase 3]
Phase 2/3 trial evaluating anakinra (ANAKINRA) for systemic-onset juvenile idiopathic arthritis completed.